These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 9173038)

  • 1. [Examination of myocardial perfusion with positron emission tomography: a clinically useful and valid method?].
    vom Dahl J
    Herz; 1997 Feb; 22(1):1-15. PubMed ID: 9173038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Assessing myocardial perfusion with positron emission tomography].
    vom Dahl J
    Z Kardiol; 2001 Nov; 90(11):835-47. PubMed ID: 11771451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Indications for clinical applications of positron emission tomography in cardiology. Position report of the PET Cardiology Study Group of the German Society of Nuclear Medicine and the Nuclear Cardiology Study Circle of the German Society of Cardiology].
    Z Kardiol; 1996 Jul; 85(7):453-68. PubMed ID: 8928543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical role of positron emission tomography in management of the cardiac patient.
    Pirich C; Schwaiger M
    Rev Port Cardiol; 2000 Feb; 19 Suppl 1():I89-100. PubMed ID: 10750444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of myocardial perfusion and viability by positron emission tomography.
    Anagnostopoulos C; Georgakopoulos A; Pianou N; Nekolla SG
    Int J Cardiol; 2013 Sep; 167(5):1737-49. PubMed ID: 23313467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography.
    Dayanikli F; Grambow D; Muzik O; Mosca L; Rubenfire M; Schwaiger M
    Circulation; 1994 Aug; 90(2):808-17. PubMed ID: 8044952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Myocardial microcirculation in humans--new approaches using MRI].
    Wacker CM; Bauer WR
    Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of tissue viability with fluorine-18-fluoro-2-deoxyglucose (FDG) and carbon-11-acetate PET imaging.
    Schröter G; Schneider-Eicke J; Schwaiger M
    Herz; 1994 Feb; 19(1):42-50. PubMed ID: 8150413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac positron emission tomography imaging.
    Machac J
    Semin Nucl Med; 2005 Jan; 35(1):17-36. PubMed ID: 15645392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography in cardiovascular disease.
    Beanlands R
    Can J Cardiol; 1996 Oct; 12(10):875-83. PubMed ID: 9191475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of coronary microvascular dysfunction in the genesis of cardiovascular diseases.
    Parodi O; Sambuceti G
    Q J Nucl Med; 1996 Mar; 40(1):9-16. PubMed ID: 8681018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of myocardial viability and coronary revascularization on clinical outcome and prognosis: a follow-up study of 161 patients with coronary heart disease].
    vom Dahl J; Altehoefer C; Büchin P; Sheehan FH; Schwarz ER; Koch KC; Schulz G; Uebis R; Schöndube F; Messmer BJ; Büll U; Hanrath P
    Z Kardiol; 1996 Nov; 85(11):868-81. PubMed ID: 9064949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Positron emission tomography].
    Schwaiger M; Pirich C
    Z Kardiol; 2000; 89 Suppl 1():59-66. PubMed ID: 10907302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative assessment of myocardial perfusion: is it of clinical relevance?
    Stollfuss JC; Kosa I; Ziegler S; Schwaiger M
    Q J Nucl Med; 1996 Mar; 40(1):76-84. PubMed ID: 8681016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Scintigraphy and positron emission tomography].
    Kaufmann PA
    Ther Umsch; 1997 Dec; 54(12):711-21. PubMed ID: 9465749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Positron emission tomography in cardiological diagnosis: principles and clinical application].
    vom Dahl J; Schwaiger M
    Schweiz Rundsch Med Prax; 1992 Oct; 81(43):1281-9. PubMed ID: 1411018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac applications of PET.
    Sarikaya I
    Nucl Med Commun; 2015 Oct; 36(10):971-85. PubMed ID: 26035516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive assessment of coronary collaterals in man by PET perfusion imaging.
    Demer LL; Gould KL; Goldstein RA; Kirkeeide RL
    J Nucl Med; 1990 Mar; 31(3):259-70. PubMed ID: 2307996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High prevalence of myocardial perfusion abnormalities on positron emission tomography in asymptomatic persons with a parent or sibling with coronary artery disease.
    Sdringola S; Patel D; Gould KL
    Circulation; 2001 Jan; 103(4):496-501. PubMed ID: 11157712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SPECT and PET in the evaluation of coronary artery disease.
    Jadvar H; Strauss HW; Segall GM
    Radiographics; 1999; 19(4):915-26. PubMed ID: 10464799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.